Serum oestradiol-17 beta, testosterone, luteinizing hormone and follicle-stimulating hormone in males with breast cancer.
作者信息
Ribeiro G G, Phillips H V, Skinner L G
出版信息
Br J Cancer. 1980 Mar;41(3):474-7. doi: 10.1038/bjc.1980.72.
Abstract
摘要
相似文献
1
Serum oestradiol-17 beta, testosterone, luteinizing hormone and follicle-stimulating hormone in males with breast cancer.
Br J Cancer. 1980 Mar;41(3):474-7. doi: 10.1038/bjc.1980.72.
2
3
4
[Serum levels of luteinizing hormone, follicle-stimulating hormone, cortisol, testosterone and estradiol in viral hepatitis].
Pol Tyg Lek. 1979 Sep 10;34(37):1449-51.
5
Hormone profile in leprosy.
Indian J Lepr. 1989 Oct;61(4):428-31.
6
Albumin-bound and non-protein-bound oestradiol and testosterone in postmenopausal breast disease.
Eur J Cancer. 1991;27(3):259-63. doi: 10.1016/0277-5379(91)90511-b.
7
Circulating hormone concentrations in women with breast cancer.
Lancet. 1976 May 22;1(7969):1100-2. doi: 10.1016/s0140-6736(76)90064-7.
8
Temporal patterns of integrated plasma hormone levels during sleep and wakefulness. II. Follicle-stimulating hormone, luteinizing hormone, testosterone and estradiol.
J Clin Endocrinol Metab. 1973 Dec;37(6):848-54. doi: 10.1210/jcem-37-6-848.
9
The gonadotrophin response to synthetic gonadotrophin-releasing hormone in males in relation to age, dose, and basal serum levels of testosterone, oestradiol-17beta and gonadotrophins.
Acta Endocrinol (Copenh). 1974 Dec;77(4):625-35. doi: 10.1530/acta.0.0770625.
10
[Steroid receptor levels in human breast carcinomas in relation to serum hormone levels in postmenopausal patients (author's transl)].
Wien Klin Wochenschr. 1981 May 29;93(11):339-42.
引用本文的文献
1
Risk factors for male breast cancer.
Am J Transl Res. 2023 Dec 15;15(12):6918-6925. eCollection 2023.
2
Risk factors for male breast cancer.
Br J Cancer. 1995 Jun;71(6):1359-62. doi: 10.1038/bjc.1995.264.
3
Adjuvant tamoxifen for male breast cancer (MBC).
Br J Cancer. 1992 Feb;65(2):252-4. doi: 10.1038/bjc.1992.50.
本文引用的文献
1
Serum oestradiol-17 beta in normal women.
Br J Cancer. 1974 Jun;29(6):462-9. doi: 10.1038/bjc.1974.98.
2
Male breast cancer. II. Metabolism of oestradiol-17 beta in men with breast cancer.
J Steroid Biochem. 1973 Sep;4(5):489-501. doi: 10.1016/0022-4731(73)90064-2.
3
Urinary estrogen excretion in men with breast cancer.
N Engl J Med. 1973 Jul 19;289(3):138-40. doi: 10.1056/NEJM197307192890307.
4
Oestrogen receptors in male breast cancer.
Biomedicine. 1976 Dec 5;25(9):327-30.
5
Changes in the pituitary-testicular system with age.
Clin Endocrinol (Oxf). 1976 Jul;5(4):349-72. doi: 10.1111/j.1365-2265.1976.tb01964.x.
6
Two methods for measurement of oestradiol-17 beta and progesterone receptors in human breast cancer and correlation with response treatment.
Eur J Cancer (1965). 1977 Oct;13(10):1133-43. doi: 10.1016/0014-2964(77)90012-3.
7
Follicle-stimulating hormone stimulates estradiol-17beta synthesis in cultured Sertoli cells.
Proc Natl Acad Sci U S A. 1975 Jul;72(7):2677-81. doi: 10.1073/pnas.72.7.2677.
8
Plasma estrogens and androgens in male breast cancer.
J Steroid Biochem. 1976 Aug;7:605-9. doi: 10.1016/0022-4731(76)90084-4.
Zotero 插件